Condition
Narcolepsy Type 1 clinical trials and research
As of November 12, 2026, Find a Trial lists 15 Narcolepsy Type 1 clinical trials that are recruiting, at sites in 19 countries (most in United States (10), France (9), Italy (6)). By phase: Phase 2/3 (4), Phase 2 (3), Phase 3 (2). The most active sponsors are Takeda (3), Alkermes, Inc. (3), Hospices Civils de Lyon (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 15Clinical trials
- 19Countries
Newest Narcolepsy Type 1 clinical trials
All recruiting trials (15)
-
Temporal interference stimulation for narcolepsy type 1
A noninvasive brain stimulation test to see if theta-burst temporal interference can help people with narcolepsy type 1.
-
Long-term test of TAK-360 in people with narcolepsy or idiopathic hypersomnia
This study tests TAK-360 over an extended period to see if it is tolerable for people with narcolepsy type 1, narcolepsy type 2, or idiopathic hypersomnia who completed an earlier TAK-360 trial.
-
TAK-360 in adults with narcolepsy Type 1 with cataplexy
This study tests TAK-360 versus placebo in adults with narcolepsy Type 1 to see if it is safe and tolerable.
-
Test of Cleminorexton vs placebo for central hypersomnolence in NT1/NT2
This study tests cleminorexton to see if it helps daytime sleepiness in adults with Narcolepsy Type 1 or Type 2 compared with a placebo.
-
ALKS 2680 in adults with narcolepsy type 1: see if it helps daytime sleepiness and cataplexy
This study tests whether ALKS 2680 helps reduce daytime sleepiness and cataplexy in adults with narcolepsy type 1 compared with a placebo.
-
ALKS 2680 for reducing daytime sleepiness and cataplexy in adults with narcolepsy type 1
This study will test whether ALKS 2680 tablets can reduce daytime sleepiness, cataplexy, and other symptoms in adults with narcolepsy type 1.
-
Pain testing for people with idiopathic REM sleep behavior disorder
This study will test whether people with idiopathic REM sleep behavior disorder feel and report pain differently using brief thermal pain tests and questionnaires.
-
Long-term ORX750 treatment for people with narcolepsy or idiopathic hypersomnia
This open-label extension will try continued ORX750 treatment in people with narcolepsy or idiopathic hypersomnia who completed the earlier ORX750 parent study.
-
Long-term treatment with ALKS 2680 for narcolepsy and idiopathic hypersomnia
This study is testing how well a new medication called ALKS 2680 works for people with narcolepsy or idiopathic hypersomnia over a long period of time.
-
Testing ORX750 for Narcolepsy and Idiopathic Hypersomnia
This study is testing a new medication called ORX750 to see if it can help people with narcolepsy or idiopathic hypersomnia feel more awake and improve their daily lives.
-
Understanding how food intake affects sleep in narcolepsy and hypersomnia patients
This study is testing how what people eat affects their sleep and daytime sleepiness in patients with narcolepsy and hypersomnia to find better ways to manage their health.
-
Exploring mind-wandering and its effects in narcolepsy and hypersomnolence
This study is testing how daydreaming affects thinking and creativity in people with narcolepsy and excessive sleepiness.
-
See if a non-drug therapy reduces nightmares in adults with narcolepsy
This study tests a talking-based therapy called imagery rehearsal therapy to see if it reduces frequent nightmares in adults with narcolepsy, with participants and sometimes their sleep partners involved in assessments.
-
Gut bacteria and bacterial translocation in people with type 1 narcolepsy versus controls
This study will test whether the gut microbiome and bacterial translocation differ in people with type 1 narcolepsy compared with people without hypersomnolence problems.
-
Evaluating TAK-861 for treating narcolepsy type 1
This study is testing a new medication called TAK-861 to see if it can help people with narcolepsy type 1 feel less sleepy during the day and reduce their sudden muscle weakness.
Related topics
Quick answers
How many Narcolepsy Type 1 clinical trials are recruiting right now?
15, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in United States (10 trials), France (9 trials), Italy (6 trials), Spain (6 trials), Australia (5 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 4, Phase 2: 3, Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.